© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Enrofloxacin Hydrochloride stands out as a vital chemical material seen frequently in the veterinary pharmaceutical world. Its use focuses on fighting bacterial infections in animals by interfering with DNA replication in pathogens. What makes it important is more than the function it serves in veterinary medicine. Recognizing the chemical’s complete identity, from its structure to its safety profile, shapes a responsible and knowledgeable handling of this raw material. You find the molecule under the formula C19H23FN4O3·HCl, revealing both its complexity and its purpose-built engineering. Each atom speaks for a role and every bond tells a story in how this chemical behaves, how it resists degradation, and the way it dissolves to form solutions that veterinarians use daily. Its hydrochloride form introduces a level of solubility and stability, which pivots the active base to a more manageable state.
Enrofloxacin Hydrochloride presents itself in several physical forms — from white to pale yellow powder, crystalline flakes, and sometimes even small pearls. The color can sometimes drift slightly, based on purity and storage conditions, but the optical identity tends to cue in on cleanliness and a dense particle arrangement. This chemical stands as a solid at room temperature, bearing a specific density that usually ranges from 1.3 to 1.5 g/cm³. Handling thousands of grams in a manufacturing context, that difference counts for a lot, especially when creating precise dosage forms. Its solubility in water allows for straightforward preparation of solutions, and in cold conditions, the substance holds its stability without clumping or settling, which matters when veterinarians demand uniform suspension for each treatment. In laboratory practice, Enrofloxacin Hydrochloride does not possess a strong odor, helping in safer laboratory conditions and daily handling. Such physical traits — powder, flake, crystalline or pearls — come from the setup of the production line and the requirements of the end user, though all share common chemical backbone and stability features.
Digging deeper, the molecular structure remains significant to both the manufacturing steps and its therapeutic use. The backbone is the quinolone ring, with the hydrochloride as a salt-forming group sitting close to the piperazine ring site. These features grant not only chemical resilience but also help it work once administered. The formula, C19H23FN4O3·HCl, spells out the presence of fluorine — a classic move in developing antibiotic substances to gain broader effectiveness. Its molecular weight comes in at about 393.9 g/mol, important for those running large-scale syntheses and when preparing high-purity API (active pharmaceutical ingredient) batches. Standard specifications put purity above 98%, usually verified by HPLC (high-performance liquid chromatography) and characterized with melting points exceeding 220°C. Moisture content gets monitored closely; excess can degrade the quality and cause hydrolysis. Particle size distribution impacts flow characteristics and the efficacy of blending during the production of veterinary tablets, injectables, or suspensions.
Trading Enrofloxacin Hydrochloride across borders demands careful attention to customs and declaration standards, captured by its Harmonized System (HS) Code. For most chemical APIs like this, the HS Code falls under 2941.90, listing it within the “antibiotics” family. Documenting the correct code avoids delays at customs and keeps import-export operations running clean. Regulatory oversight insists on detailed certificates of analysis, encompassing safety data sheets, impurity profiles, and storage instructions to protect handlers and the end users. By keeping tight to these requirements, manufacturers and traders keep legal and safety hurdles away from veterinarians and end customers, protecting animal health and also, indirectly, food safety for humans.
Knowing the health and environmental profile of Enrofloxacin Hydrochloride clears up many questions about safe use. The substance brings antibacterial power, but careless handling throws up its own risks. Exposure by inhalation or direct contact with powder or solutions may irritate skin, eyes, or the respiratory tract. Chronic exposure in manufacturing settings points to possible allergic reactions in sensitive individuals. As a result, working with the material in a pharmaceutical plant or laboratory involves using gloves, safety goggles, and local exhaust ventilation. Enrofloxacin Hydrochloride does not rank as a particularly explosive or flammable compound, though its dust can pose minimal risk under static-prone conditions, and so anti-static protocols help in storage and transfer operations. SDS (Safety Data Sheets) reference its environmental fate: improper disposal might contribute to bacterial resistance in the wild, a reminder of why responsible waste management and careful tracking of expired stock count toward genuine stewardship. Most operations keep it in cool, dry, and tightly sealed containers, preventing light or humidity from compromising quality.
Knowing all these properties, the significance of Enrofloxacin Hydrochloride stretches beyond the factory floor or veterinary clinic. The product anchors global livestock health, especially on large farms in regions where bacterial disease threatens both animal welfare and the food chain. For me, having handled the logistic side of pharmaceutical imports, the push for responsible sourcing and traceable material underscores every shipment. Monitoring purity and authenticity helps block counterfeit entries into the market, where unknown impurities might create more problems than solutions. Problems like antimicrobial resistance have grown louder in the scientific and farming communities, pressing suppliers and practitioners to track every step from synthesis through storage and disposal. Solutions hinge on transparency, verified test results, and end-user education about cautious and appropriate antibiotic administration — a collaboration echoing through supply chains. Policymakers and manufacturers adjusting formulations, container sizes, or modifying dosing mechanisms often draw on these detailed property lists to inform decisions. As regulations strengthen, and with field insights echoing up the policy chain, the pressure to maintain precision and responsibility grows stronger — for every gram, every shipment, and every animal treated.
